资讯
LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
免疫疗法
Enlivex to Present 3-Month Topline Data from Phase IIa Moderate/Severe Knee Osteoarthritis Trial on August 18 Webinar
免疫疗法细胞疗法临床结果
Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity
临床研究
Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update
引进/卖出临床结果财报高管变更
Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme
免疫疗法
Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for Primary Sjögren's Disease with Telitacicept, a Dual BAFF/APRIL Inhibitor
临床结果上市批准
Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights
财报快速通道基因疗法
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
细胞疗法快速通道免疫疗法
微生物疗法
临床结果上市批准
Eureka LS:
全新生物医药AI Agent 覆盖科研全链路,让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。